Naringenin alleviates nonalcoholic steatohepatitis in middle-aged Apoe−/−mice: role of SIRT1
Abstract
Background Naringenin is naturally isolated from citrus fruits possessing many pharmacological activities. However, little is known about the effect of naringenin on nonalcoholic steatohepatitis (NASH) in the model of metabolic syndrome.Purpose The present study is aimed to investigate the effect of naringenin on NASH in 12-mo-old male ApoE-/- mice and its possible underlying mechanism.Methods In vivo, 12-mo-old male ApoE-/- mice were administrated with naringenin by intragastric gavage for 12 weeks. At the end of experiment, the blood samples and liver tissues were collected. Metabolic parameters in serum, levels of triglyceride, cholesterol and hydroxyproline, activities of antioxidant enzymes, and content of inflammatory cytokines (TNF-α and IL-6) in liver were examined by corresponding assay kits. Pathological changes in liver were observed by hematoxylin-eosin, oil red O, masson's trichrome, picro-sirius red and senescence β-galactosidase staining. Dihydroethidium was used for detection of reactive oxygen species (ROS). In vitro, AML-12 cells were treated with oleic acid in the presence or absence of naringenin for 24 h. Transfection of SIRT1 siRNA was also conducted in vitro. Lipid accumulation, cellular ROS generation, malondialdehyde content, antioxidant enzyme activities and secretion levels of TNF-α and IL-6 were examined. Both in vivo and in vitro, gene expressions were detected by real-time PCR or western blot.Results Naringenin administration improved metabolic parameters, suppressed hepatic steatosis, regulated expression of genes involved in lipid metabolism (FASN, SCD1, PPARα and CPT1α), reduced hepatic fibrosis and cell senescence, inhibited hepatic inflammation as evidenced by the decreased macrophage recruitment and content of TNF-α and IL-6, and reduced hepatic oxidative stress by suppressing ROS generation and normalizing activities of antioxidant enzymes. Notably, naringenin administration increased hepatic SIRT1 protein expression and activity along with the increased deacetylation of liver kinase B1 (LKB1), PGC1α and NF-κB. In vitro study, the benefits of naringenin on lipid accumulation, oxidative stress and inflammation were diminished by SIRT1 siRNA transfection.Conclusions These results indicate that naringenin administration may be a potential curative therapy for NASH treatment and the activation of hepatic SIRT1-mediated signaling cascades is involved in its beneficial effects.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Beside antioxidant activity, flavonoids have anti-inflammatory, vasodilator, anticoagulant, cardioprotective, anti-diabetic, neuroprotective, and anti-obesity activities, making them of interest as anti-aging compounds.
“Beside the antioxidant activity, flavonoids have anti-inflammatory, vasodilator, anticoagulant, cardioprotective, anti-diabetic, neuroprotective, and anti-obesity activities, which make them of great interest as anti-aging compounds (Table 3) [228,229,230,231,232,233,234,235,236,237,238,239,240,241,242,243,244,245,246,247,248,249,250,251,252,253,254,255,256,257].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [230]
Cites
Chalasani, N., Younossi, Z., Lavine, J. E., Charlton, M., Cusi, K., Rinella, M., Harrison, S. A., Brunt, E. M., & Sanyal, A. J. (2018) · Hepatology · doi:10.1002/hep.29367 · Cited by 7,239 · see citing works
Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan
Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W., Lavu, S., Wood, J. G., Zipkin, R. E., Chung, P., Kisielewski, A., Zhang, L.-L., et al. (2003) · Nature · doi:10.1038/nature01960 · Cited by 3,796 · see citing works
Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein E
Zhang, S. H., Reddick, R. L., Piedrahita, J. A., & Maeda, N. (1992) · Science · doi:10.1126/science.1411543 · Cited by 2,237 · see citing works
Cause, Pathogenesis, and Treatment of Nonalcoholic Steatohepatitis
Diehl, A. M., & Day, C. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1503519 · Cited by 1,283 · see citing works
Kauppinen, A., Suuronen, T., Ojala, J. O., Kaarniranta, K., & Salminen, A. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2013.06.007 · Cited by 1,001 · see citing works
SIRT1 Modulation of the Acetylation Status, Cytosolic Localization, and Activity of LKB1
Lan, F., Cacicedo, J. M., Ruderman, N., & Ido, Y. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805711200 · Cited by 825 · see citing works
Alam, M. A., Subhan, N., Rahman, M., Uddin, S. J., Reza, H. M., & Sarker, S. D. (2014) · Advances in Nutrition · doi:10.3945/an.113.005603 · Cited by 792 · see citing works
SIRT1 and aging related signaling pathways
Chen, C., Zhou, M., Ge, Y., & Wang, X. (2020) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2020.111215 · Cited by 693 · see citing works
Emerging roles of SIRT1 in fatty liver diseases
Ding, R., Bao, J., & Deng, C. (2017) · International Journal of Biological Sciences · doi:10.7150/ijbs.19370 · Cited by 359 · see citing works
Beneficial effects of naringenin in liver diseases: Molecular mechanisms
Hernández‐Aquino, E., & Muriel, P. (2018) · World Journal of Gastroenterology · doi:10.3748/wjg.v24.i16.1679 · Cited by 349 · see citing works
SirT1 Regulation of Antioxidant Genes Is Dependent on the Formation of a FoxO3a/PGC-1α Complex
Olmos, Y., Sánchez-Gómez, F. J., Wild, B., García-Quintáns, N., Cabezudo, S., Lamas, S., & Monsalve, M. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4713 · Cited by 320 · see citing works
Farrell, G., Schattenberg, J. M., Leclercq, I., Yeh, M. M., Goldin, R., Teoh, N., & Schuppan, D. (2019) · Hepatology · doi:10.1002/hep.30333 · Cited by 313 · see citing works
Wang, Q., Ou, Y., Hu, G., Wen, C., Yue, S., Chen, C., Xu, L., Xie, J., Dai, H., Xiao, H., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14938 · Cited by 310 · see citing works
Mouse models of nonalcoholic steatohepatitis in preclinical drug development
Hansen, H. H., Feigh, M., Veidal, S. S., Rigbolt, K. T. G., Vrang, N., & Fosgerau, K. (2017) · Drug Discovery Today · doi:10.1016/j.drudis.2017.06.007 · Cited by 274 · see citing works
Salomone, F., Godos, J., & Zelber‐Sagi, S. (2015) · Liver International · doi:10.1111/liv.12975 · Cited by 261 · see citing works
Naringenin and naringin in cardiovascular disease prevention: A preclinical review
Moghaddam, R. H., Samimi, Z., Moradi, S. Z., Little, P. J., Xu, S., & Farzaei, M. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173535 · Cited by 220 · see citing works
An Overview of Lipid Metabolism and Nonalcoholic Fatty Liver Disease
Pei, K., Gui, T., Kan, D., Feng, H., Jin, Y., Yang, Y., Zhang, Q., Du, Z., Gai, Z., Wu, J., et al. (2020) · BioMed Research International · doi:10.1155/2020/4020249 · Cited by 209 · see citing works
Papatheodoridi, A., Chrysavgis, L., Koutsilieris, M., & Chatzigeorgiou, A. (2019) · Hepatology · doi:10.1002/hep.30834 · Cited by 206 · see citing works
Ore, A., & Akinloye, O. A. (2019) · Medicina · doi:10.3390/medicina55020026 · Cited by 180 · see citing works
Saadati, S., Sadeghi, A., Mansour, A., Yari, Z., Poustchi, H., Hedayati, M., Hatami, B., & Hekmatdoost, A. (2019) · BMC Gastroenterology · doi:10.1186/s12876-019-1055-4 · Cited by 164 · see citing works
Naringenin Ameliorates Acute Inflammation by Regulating Intracellular Cytokine Degradation
Jin, L., Zeng, W., Zhang, F., Zhang, C., & Liang, W. P. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1602016 · Cited by 111 · see citing works
Anti-inflammatory role of naringenin in rats with ethanol induced liver injury
Jayaraman, J., Jesudoss, V. A. S., Menon, V. P., & Nalini, N. (2012) · Toxicology Mechanisms and Methods · doi:10.3109/15376516.2012.707255 · Cited by 103 · see citing works
Naringenin prevents experimental liver fibrosis by blocking TGFβ-Smad3 and JNK-Smad3 pathways
Hernández‐Aquino, E., Zarco, N., Casas‐Grajales, S., Ramos‐Tovar, E., Flores‐Beltrán, R. E., Arauz, J., Shibayama, M., Favari, L., Tsutsumi, V., Segovia, J., et al. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i24.4354 · Cited by 87 · see citing works
Testai, L., Piragine, E., Piano, I., Flori, L., Pozzo, E. D., Miragliotta, V., Pirone, A., Citi, V., Mannelli, L. D. C., Brogi, S., et al. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/4650207 · Cited by 87 · see citing works
Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis
Kessoku, T., Imajo, K., Honda, Y., Kato, T., Ogawa, Y., Tomeno, W., Kato, S., Mawatari, H., Fujita, K., Yoneda, M., et al. (2016) · Scientific Reports · doi:10.1038/srep22251 · Cited by 85 · see citing works
Kemper, J. K., Choi, S.-E., & Kim, D.-H. (2013) · Vitamins and hormones · doi:10.1016/b978-0-12-407766-9.00016-x · Cited by 65 · see citing works
Zeng, Y., Hua, Y. Q., Wang, W., Zhang, H., & Xu, X. L. (2020) · Biochemical Pharmacology · doi:10.1016/j.bcp.2020.113927 · Cited by 63 · see citing works
Self-citationApolipoprotein E and its role in aging and survival
Bonomini, F., Filippini, F., Hayek, T., Aviram, M., Keidar, S., Rodella, L. F., Coleman, R., & Rezzani, R. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.11.006 · Cited by 60 · see citing works
Pompili, S., Vetuschi, A., Gaudio, E., Tessitore, A., Capelli, R., Alesse, E., Latella, G., Sferra, R., & Onori, P. (2020) · Nutrition · doi:10.1016/j.nut.2020.110782 · Cited by 56 · see citing works
Hepatoprotective Effects of Resveratrol in Non-Alcoholic Fatty Live Disease
Tejada, S., Capó, X., Mascaró, C. M., et al. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666200417165801 · Cited by 40 · see citing works
Pioglitazone attenuates aging-related disorders in aged apolipoprotein E deficient mice
Shen, D., Li, H., Zhou, R., Liu, M., Yu, H., & Wu, D. (2017) · Experimental Gerontology · doi:10.1016/j.exger.2017.12.002 · Cited by 39 · see citing works
Gu, L., Cai, N., Lyu, Y., Yao, L., Wang, F., Xu, H. Y., Hu, Z., Li, H., & Xu, X. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b05632 · Cited by 37 · see citing works
Self-citationGuclu, A., Erdur, F., & Türkmen, K. (2015) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0035-1565067 · Cited by 33 · see citing works
Xu, J., Peng, Y., Zeng, Y., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20071617 · Cited by 31 · see citing works
Self-citationApolipoprotein E deficiency and a mouse model of accelerated liver aging
Bonomini, F., Rodella, L. F., Moghadasian, M. H., Lonati, C., & Rezzani, R. (2013) · Biogerontology · doi:10.1007/s10522-013-9424-9 · Cited by 24 · see citing works
Mohan, S. K., Veeraraghavan, V. P., & Jainu, M. (2015) · Europe PMC (PubMed Central) · Cited by 22 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence
Varesi, A., Chirumbolo, S., Campagnoli, L. I. M., Pierella, E., Piccini, G. B., Carrara, A., Ricevuti, G., Scassellati, C., Bonvicini, C., & Pascale, A. (2022) · Antioxidants · doi:10.3390/antiox11071224 · Cited by 145 · see citing works
- Authors
- Hua, Y. Q., Zeng, Y., Xu, J., & Xu, X. L.
- Affiliations
- Nantong University (CN)
- Corresponding author
- Xu, Xiao Le
- Venue
- Phytomedicine
- Publisher
- Elsevier BV
- Published
- 2021-01
- Volume
- 81
- Pages
- 153412
- ISSN
- 0944-7113 (ISSN-L)
- OpenAlex
- W3105272009
- Cited by
- 137
- References
- 36
- Citations by year
- 2026: 36 · 2025: 29 · 2024: 27 · 2023: 24 · 2022: 15 · 2021: 5
- FWCI
- 7.88
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Phytomedicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China
- Topics
- Health Sciences › Medicine › Epidemiology › Liver Disease Diagnosis and Treatment
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Health Sciences › Medicine › Pharmacology › Flavonoids in Medical Research
- Keywords
- naringenin, nonalcoholic steatohepatitis, SIRT1, metabolic syndrome, hepatic steatosis, liver fibrosis, oxidative stress, inflammation, lipid metabolism, oleic acid-induced lipid accumulation, LKB1, PGC-1α, NF-κB, macrophage recruitment, citrus flavonoids, ApoE-deficient mice, AML12 cells
- MeSH terms
- Mice, Knockout, ApoE, Animals, Liver, Liver Cirrhosis, Male, Mice, Inbred C57BL, Nuclear Proteins, Transcription Factors, NF-kappa B, Reactive Oxygen Species, Oxidative Stress, Flavanones, Lipid Metabolism, Mice, Sirtuin 1, Non-alcoholic Fatty Liver Disease
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review